Inovio Pharmaceuticals Newsroom

Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 Loss per Share (Vs US$1.52 Loss in 3Q 2023)

Yahoo FinanceNov 16 21:54

Inovio Pharma Is Maintained at Sector Perform by RBC Capital

Dow JonesNov 16 01:41 · Ratings

Inovio Pharmaceuticals Analyst Ratings

BenzingaNov 16 01:29 · Ratings

RBC Capital Maintains Inovio Pharmaceuticals(INO.US) With Hold Rating, Cuts Target Price to $6

Futu NewsNov 15 20:33 · Ratings

RBC Capital Sticks to Its Hold Rating for Inovio Pharmaceuticals (INO)

TipRanksNov 15 19:47 · Ratings

Express News | Inovio Pharmaceuticals Inc : RBC Cuts Target Price to $6 From $7

BreakingsNov 15 12:49

Inovio Pharmaceuticals Advances DNA Medicine Development

TipRanksNov 15 12:03

Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.

① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.

cls.cnNov 15 10:14

Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 15 09:03 · Conference Call

Express News | Inovio Pharmaceuticals Inc: Estimates Its Cash Runway to Extend Into Q3 of 2025

BreakingsNov 15 05:13

Inovio Pharmaceuticals | 10-Q: Quarterly report

SECNov 15 05:09 · Announcements

Inovio Pharmaceuticals Q3 2024 GAAP EPS $(0.89) Beats $(1.15) Estimate

BenzingaNov 15 05:07

Inovio Pharmaceuticals Q3 24 Earnings Conference Call At 4:30 PM ET

RTTNewsNov 15 04:04

Here Are the Major Earnings After the Close Today

Seeking AlphaNov 14 23:00

Earnings Scheduled For November 14, 2024

BenzingaNov 14 16:32

A Preview Of Inovio Pharmaceuticals's Earnings

BenzingaNov 14 00:02

Immunology Data Shows INOVIO's INO-3107 Induced Expansion Of New Clonal T Cells That Infiltrate Airway Tissue And Correspond With Reduction Of Surgeries For RRP Patients Observed In Phase 1/2 Trial

BenzingaNov 13 21:12

Express News | Immunology Data Shows Inovio's Ino-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for Rrp Patients Observed in Phase 1/2 Trial

BreakingsNov 13 21:00

Earnings Preview: INO to Report Financial Results Post-market on November 14

$Inovio Pharmaceuticals(INO.US)$ is scheduled to release its financial results post-market on November 14 ET. Earnings PreviewAnalysts estimate $Inovio Pharmaceuticals(INO.US)$ to post revenue of USD1

Futu NewsNov 9 09:00

INOVIO to Present at Upcoming Scientific Conferences

PR NewswireNov 7 05:05